Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.

Clinical and Vaccine Immunology

Volumn 14, Issue 8, 2007, Pages 1045-1049

  Caballero, Zuleima C ^a,b   Sousa, Octavio E ^b   Marques, Waldelania P ^c   Saez Alquezar, Amadeo ^c,e   Umezawa, Eufrosina Setsu ^a,d  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b Panel Assessoria and Controle de Qualidade   (Brazil)

^c UNIVERSIDAD DE PANAMÁ   (Panama)

^d NONE   (Brazil)

^e NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PARASITE ANTIGEN; RECOMBINANT ANTIGEN; PROTOZOON ANTIBODY; RECOMBINANT PROTEIN;

ADULT; ANTIGEN EXPRESSION; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS REACTION; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIMASTIGOTE; FEMALE; HEMAGGLUTINATION TEST; HUMAN; INTERMETHOD COMPARISON; LEISHMANIA; LEISHMANIASIS; MALE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRYPANOSOMA; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS; TRYPOMASTIGOTE; WESTERN BLOTTING; ANALYTICAL EQUIPMENT; ANIMAL; BLOOD; CLASSIFICATION; EVALUATION; GENETICS; IMMUNOLOGY; PARASITOLOGY;

ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CHAGAS DISEASE; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; LEISHMANIA; REAGENT KITS, DIAGNOSTIC; RECOMBINANT PROTEINS; SENSITIVITY AND SPECIFICITY; TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 35248891158     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00127-07     Document Type: Article

References (23)

1. Centers for Disease Control and Prevention (CDC). 2006. Chagas disease after organ transplantation-Los Angeles, California. Morb. Mortal. Wkly. Rep. 55:798-800.
2. Frank, F. M., M. M. Fernandez, N. J. Taranto, S. P. Cajal, R. A. Margni, E. Castro, V. Thomaz-Soccol, and E. L. Malchiodi. 2003. Characterization of human infection by Leishmania spp. in the Northwest of Argentina: immune response, double infection with Trypanosoma cruzi and species of Leishmania involved. Parasitology 126:31-39.
3. Kirchhoff, L. V., P. Paredes, A. Lomeli-Guerrero, M. Paredes-Espinoza, C. S. Ron-Guerrero, M. Delgado-Mejia, and J. G. Pena-Munoz. 2006. Transfusion-associated Chagas disease (American trypanosomiasis) in Mexico: implications for transfusion medicine in the United States. Transfusion 46:298-304.
4. Leiby, D. A., S. Wendel, D. T. Takaoka, R. M. Fachini, L. C. Oliveira, and M. A. Tibbals. 2000. Serologic testing for Trypanosoma cruzi: comparison of radioimmunoprecipitation assay with commercially available indirect immunofluorescence assay, indirect hemagglutination assay, and enzyme-linked immunosorbent assay kits. J. Clin. Microbiol. 38:639-642.
5. Leiby, D. A., R. M. Herron, E. J. Read, B. A. Lenes, and R. J. Stumpf. 2002. Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission. Transfusion 42:549-555.
6. Malan, A. K., E. Avelar, S. E. Litwin, H. R. Hill, and C. M. Litwin. 2006. Serological diagnosis of Trypanosoma cruzi: evaluation of three enzyme immunoassays and an indirect immunofluorescent assay. J. Med. Microbiol. 55:171-178.
7. Marcon, G. E., P. D. Andrade, D. M. de Albuquerque, J. S. Wanderley, E. A. Almeida, M. E. Guariento, and S. C. B. Costa. 2002. Use of a nested polymerase chain reaction (N-PCR) to detect Trypanosoma cruzi in blood samples from chronic chagasic patients and patients with doubtful serologies. Diagn. Microbiol. Infect. Dis. 43:39-43.
8. Moncayo, A., and M. I. Ortiz Yanine. 2006. An update on Chagas disease (human American trypanosomiasis). Ann. Trop. Med. Parasitol. 100:663-677.
9. Nowicki, M. J., C. Chinchilla, L. Corado, L. Matsuoka, R. Selby, F. Steurer, T. Mone, R. Mendez, and S. Aswad. 2006. Prevalence of antibodies to Trypanosoma cruzi among solid organ donors in Southern California: a population at risk. Transplantation 81:477-479.
10. Oelemann, W. M. R., M. G. M. Teixeira, G. C. Verissimo-da-Costa, J. Borges-Pereira, J. A. De Castro, J. R. Coura, and J. M. Peralta. 1998. Evaluation of three commercial enzyme-linked immunosorbent assays for diagnosis of Chagas' disease. J. Clin. Microbiol. 36:2423-2427.
11. Palau, M. T., A. J. Mejia, U. Vergara, and C. A. Zuniga. 2003. Action of Trypanosoma rangeli in infections with virulent Trypanosoma cruzi populations. Mem. Inst. Oswaldo Cruz 98:543-548.
12. Ramirez, L. E., E. Lages-Silva, F. Alvarenga-Franco, A. Matos, N. Vargas, O. Fernandes, and B. Zingales. 2002. High prevalence of Trypanosoma rangeli and Trypanosoma cruzi in opossums and triatomids in a formerly-endemic area of Chagas disease in Southeast Brazil. Acta Trop. 84:189-198.
13. Saldana, A., and O. E. Souza. 1996. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi. J. Parasitol. 82: 363-366.
14. Saldana, A., F. Samudio, A. Miranda, L. M. Herrera, S. P. Saavedra, L. Caceres, V. Bayard, and J. E. Calzada. 2005. Predominance of Trypanosoma rangeli infection in children from a Chagas disease endemic area in the west-shore of the Panama canal. Mem. Inst. Oswaldo Cruz 100:729-731.
15. Salles, N. A., E. C. Sabino, M. G. Cliquet, J. Eluf-Neto, A. Mayer, C. Almeida-Neto, M. C. Mendonca, P. Dorliach-Llacer, D. F. Chamone, and A. Saéz-Alquézar. 1996. Risk of exposure to Chagas' disease among seroreactive Brazilian blood donors. Transfusion 36:969-973.
16. Salomone, O. A., A. L. Basquiera, A. Sembaj, A. M. Aguerri, M. E. Reyes, M. Omelianuk, R. A. Fernandez, J. Enders, A. Palma, J. M. Barral, and R. J. Madoery. 2003. Trypanosoma cruzi in persons without serologic evidence of disease, Argentina. Emerg. Infect. Dis. 9:1558-1562.
17. Silveira, J. F., E. S. Umezawa, and A. O. Luquetti. 2001. Chagas disease: recombinant Trypanosoma cruzi antigens for serological diagnosis. Trends Parasitol. 17:286-291.
18. Silveira-Lacerda, E. P., A. G. Silva, S. Favoreto, Jr., M. A. Souza, N. Kesper, A. Botelho-Filho, and E. S. Umezawa. 2004. Chagas disease: application of TESA-blot in inconclusive sera from a Brazilian blood bank. Vox Sang. 87:204-207.
19. Tobler, L. H., P. Contestable, L. Pitina, H. Groth, S. Shaffer, G. R. Blackburn, H. Warren, S. R. Lee, and M. P. Busch. 2007. Evaluation of a new enzyme-linked immunosorbent assay for detection of Chagas antibody in US blood donors. Transfusion 7:90-96.
20. Umezawa, E. S., M. S. Nascimento, N. Kesper, Jr., J. R. Coura, J. Borges-Pereira, A. C. Junqueira, and M. E. Camargo. 1996. Immunoblot assay using excreted-secreted antigens of Trypanosoma cruzi in serodiag-nosis of congenital, acute, and chronic Chagas' disease. J. Clin. Microbiol. 34:2143-2147.
21. Umezawa, E. S., S. F. Bastos, J. R. Coura, M. J. Levin, A. Gonzalez, R. Rangel-Aldao, B. Zingales, A. O. Luquetti, and J. F. Silveira. 2003. An improved serodiagnostic test for Chagas' disease employing a mixture of Trypanosoma cruzi recombinant antigens. Transfusion 43:91-97.
22. Wendel, S. 1998. Transfusion-transmitted Chagas disease. Curr. Opin. Hematol. 5:406-411.
23. Zarate-Blades, C. R., M. S. Nascimento, J. F. da Silveira, and E. S. Umezawa. 2007. Diagnostic performance of tests based on Trypanosoma cruzi excreted-secreted antigens in an endemic area for Chagas disease in Bolivia. Diagn. Microbiol. Infect. Dis. 57:229-232.